Posted in | News | Laser | Imaging

Lockheed Martin Receives Direct Commercial Sale Contract to Integrate Sniper ATP on Japan’s F-2 Aircraft

Lockheed Martin received a direct commercial sale contract through Mitsubishi Heavy Industries to integrate the Sniper® Advanced Targeting Pod (ATP) onto the Japan Air Self-Defense Force’s (JASDF) F-2 aircraft.

This initial contract, awarded in 2014, includes a Sniper pod, spares and support equipment for integration. The F-2 is the eighth aircraft platform to be equipped with Sniper ATP, joining variants of the F-15, F-16, F-18, A-10, B-1, B-52 and Harrier.

“Sniper ATP’s proven performance and low life cycle cost will provide necessary support to the JASDF mission,” said Marc Nazon, Sniper international program manager at Lockheed Martin Missiles and Fire Control. “Integrating Sniper ATP on the F-2 also enables increased collaboration in U.S. Air Force and JASDF joint combat operations.”

Lockheed Martin will work with Mitsubishi Heavy Industries, the prime aircraft manufacturer, to complete Sniper ATP integration on the F-2. Follow-on contracts are expected to include additional pods, spares, logistics and support equipment for the F-2 fleet.

Sniper ATP offers pilots high-resolution imagery for precision targeting and non-traditional intelligence, surveillance and reconnaissance missions. It detects, identifies, automatically tracks and laser designates small tactical targets at long ranges and supports employment of all laser- and GPS-guided weapons against multiple fixed and moving targets.

For additional information, visit our website: www.lockheedmartin.com/sniper.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.